Reflecting on 2024, we are deeply grateful for your research endeavors and trust. Your innovation and support have driven our growth and inspired us t...
READ MOREWe are thrilled to announce that ARENSIA’s clinic in Ukraine has successfully dosed the very first patient in an advanced Phase 1 study for Non-...
READ MOREWith over a decade of specialized expertise in conducting sophisticated Phase IB and II trials, including pioneering first-in-class and best-in-class ...
READ MORESince its launch last year, ARENSIA’s Research Clinic in Phoenix, Arizona, has made remarkable progress, playing a pivotal role in Phase IB and ...
READ MOREIn Ukraine alone, rare diseases like IPF affect 10-15 people out of 100.000 population, typically diagnosed in individuals over 40. Without treatment,...
READ MOREWe love being in the lead! ARENSIA has once again achieved a significant milestone by enrolling the first patient globally, this time in a complex mul...
READ MOREToday, we honor the remarkable achievements, strength, and resilience of women worldwide. Let's stand united, empower each other, and continue bre...
READ MOREThe Health Authority (HA) of Moldova has introduced a 10-day fast-track review timeline for all phases (I-III) of clinical trials, with the regular re...
READ MOREFollowing a resonant success from San Francisco, we are thrilled to announce the next edition in the summit series: "RACE FOR PROOF OF CONCEPT...
READ MORE🔊 FIRST CALL! LIVE WEBINAR 📈 CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNITIES 📅 Monday, February 5, 2024 ⏰ 5:00 PM CET / 11:00 A...
READ MOREThe New Year starts with great news! The ARENSIA website is now available in Mandarin! This is a result of the growing interest of companies from the ...
READ MOREWe are delighted to announce the opening of ARENSIA Research Clinic in the USA, located in Phoenix, Arizona! Our mission for the clinic in the US a...
READ MORE